Two Sigma Investments’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $203K | Sell |
4,300
-2,500
| -37% | -$128K | ﹤0.01% | 4777 |
|
|
2026
Q1 | $403K | Buy |
+6,800
| New | +$441K | ﹤0.01% | 3875 |
|
|
2025
Q3 | – | Sell |
-6,567
| Closed | -$524K | – | 3852 |
|
|
2025
Q2 | $524K | Sell |
6,567
-30,303
| -82% | -$2.53M | ﹤0.01% | 2567 |
|
|
2025
Q1 | $3.17M | Sell |
36,870
-46,412
| -56% | -$3.81M | 0.01% | 1411 |
|
|
2024
Q4 | $6.5M | Sell |
83,282
-36,426
| -30% | -$2.83M | 0.01% | 955 |
|
|
2024
Q3 | $8.63M | Buy |
119,708
+4,757
| +4% | +$337K | 0.02% | 829 |
|
|
2024
Q2 | $7.91M | Buy |
114,951
+98,602
| +603% | +$6.68M | 0.02% | 804 |
|
|
2024
Q1 | $1.19M | Buy |
16,349
+5,898
| +56% | +$394K | ﹤0.01% | 1846 |
|
|
2023
Q4 | $640K | Sell |
10,451
-63,642
| -86% | -$3.78M | ﹤0.01% | 2331 |
|
|
2023
Q3 | $4.24M | Buy |
74,093
+16,847
| +29% | +$1.02M | 0.01% | 987 |
|
|
2023
Q2 | $3.4M | Buy |
57,246
+26,555
| +87% | +$1.59M | 0.01% | 1112 |
|
|
2023
Q1 | $1.92M | Sell |
30,691
-70,837
| -70% | -$4.42M | 0.01% | 1406 |
|
|
2022
Q4 | $6.36M | Sell |
101,528
-60,263
| -37% | -$3.46M | 0.02% | 745 |
|
|
2022
Q3 | $8.06M | Sell |
161,791
-24,519
| -13% | -$1.36M | 0.03% | 567 |
|
|
2022
Q2 | $11M | Buy |
186,310
+35,933
| +24% | +$1.98M | 0.04% | 477 |
|
|
2022
Q1 | $7.96M | Buy |
150,377
+37,891
| +34% | +$2.19M | 0.02% | 697 |
|
|
2021
Q4 | $6.82M | Buy |
112,486
+30,876
| +38% | +$1.83M | 0.01% | 1015 |
|
|
2021
Q3 | $4.58M | Buy |
+81,610
| New | +$4.48M | 0.01% | 1297 |
|
|
2021
Q1 | – | Sell |
-31,977
| Closed | -$1.11M | – | 4153 |
|
|
2020
Q4 | $1.11M | Buy |
31,977
+15,172
| +90% | +$539K | ﹤0.01% | 1906 |
|
|
2020
Q3 | $612K | Sell |
16,805
-94,426
| -85% | -$3.51M | ﹤0.01% | 2087 |
|
|
2020
Q2 | $4.18M | Buy |
111,231
+90,455
| +435% | +$3.62M | 0.02% | 724 |
|
|
2020
Q1 | $762K | Buy |
+20,776
| New | +$807K | 0.01% | 1626 |
|
|
2018
Q1 | – | Sell |
-16,274
| Closed | -$723K | – | 3417 |
|
|
2017
Q4 | $723K | Buy |
+16,274
| New | +$741K | ﹤0.01% | 2179 |
|
|
2016
Q4 | – | Sell |
-42,547
| Closed | -$2.05M | – | 3421 |
|
|
2016
Q3 | $2.05M | Buy |
42,547
+2,463
| +6% | +$125K | 0.01% | 1433 |
|
|
2016
Q2 | $2.22M | Sell |
40,084
-6,906
| -15% | -$380K | 0.01% | 1204 |
|
|
2016
Q1 | $2.51M | Buy |
+46,990
| New | +$2.31M | 0.01% | 1051 |
|
|
2014
Q3 | – | Sell |
-11,937
| Closed | -$405K | – | 1971 |
|
|
2014
Q2 | $405K | Sell |
11,937
-14,678
| -55% | -$470K | ﹤0.01% | 1715 |
|
|
2014
Q1 | $726K | Sell |
26,615
-191,462
| -88% | -$5.69M | ﹤0.01% | 1337 |
|
|
2013
Q4 | $7.81M | Buy |
218,077
+57,064
| +35% | +$1.9M | 0.04% | 489 |
|
|
2013
Q3 | $4.85M | Buy |
161,013
+153,340
| +1,998% | +$5.01M | 0.03% | 540 |
|
|
2013
Q2 | $223K | Buy |
+7,673
| New | +$216K | ﹤0.01% | 1745 |
|
Other funds holding PBH
AI
BIP
Two Sigma Investments's PBH Position: Q2 2026 in Review
Two Sigma Investments reduced its Prestige Consumer Healthcare (PBH) stake by 37% in Q2 2026, selling an estimated $128K and leaving 4,300 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #4777.
Two Sigma Investments first reported a position in PBH in Q2 2013 and has held it in 31 quarters since. The position peaked at $11M in Q2 2022. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Two Sigma Investments held 4,300 shares of Prestige Consumer Healthcare worth $203K as of Q2 2026.
- Two Sigma Investments sold 2,500 Prestige Consumer Healthcare shares in Q2 2026, an estimated $128K.
- Prestige Consumer Healthcare made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #4777 holding.
- Two Sigma Investments first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 31 quarters since.
- Two Sigma Investments's Prestige Consumer Healthcare position peaked at $11M in Q2 2022.
- 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.